Prognosis (chance of survival) and treatment decisions are guided mainly by tumor stage, tumor grade, hormone receptor status and HER2 status. The molecular subtype of your tumor is not part of your pathology report and is not used to guide your treatment.
Molecular subtypes are used mostly in research settings and are not part of a standard breast cancer diagnosis. There are many other less common molecular subtypes, including claudin-low and molecular apocrine types. These subtypes also appear in ductal carcinoma in situ (DCIS). Most studies divide breast cancer into 4 main molecular subtypes: The complex profile of each subtype is determined using molecular and genetic information from tumor cells. Making changes to an attribute rule requires an exclusive lock on the underlying dataset.Researchers are studying how molecular subtypes of breast cancer may be useful in planning treatment and developing new therapies.
The Attribute Rules view is read-only when accessed from an ArcGIS Pro basic license, web feature layer, or database connection as a user that is not the data owner.